Agency / Source: Thales Group

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Institut Curie and Thales Team to Create World-leading French Industrial Ecosystem in Very High-energy Electron FLASH Radiotherapy - FLASH radiotherapy using low-energy electron accelerators has already been shown to be effective for patients undergoing treatment for skin cancers - Curie.fr / ThalesGroup.com
Institut Curie and Thales Team to Create World-leading French Industrial Ecosystem in Very High-energy Electron FLASH Radiotherapy

 

PRZOOM - /newswire/ - Paris, Ile-de-France, France, 2022/07/11 - FLASH radiotherapy using low-energy electron accelerators has already been shown to be effective for patients undergoing treatment for skin cancers - Curie.fr / ThalesGroup.com. Euronext: HO

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Radiotherapy: the FLASH revolution
Discovered in 2014 at the Institut Curie laboratories by the team led by Dr Vincent Favaudon, the FLASH effect promises to be a real paradigm shift in radiotherapy. Ever since the medical benefits of radiotherapy were demonstrated, therapeutic programmes have had to be conducted in several sessions to limit the side effects of the radiation. Using very intense rays delivered in less than a second, the ultra-high dose rate FLASH technique destroys tumour cells without harming healthy tissue. If the next stages of research validate future clinical applications, FLASH radiotherapy could prove to be a revolution in cancer treatment.

“With innovative approaches that reduce the sensitivity of healthy tissue to radiation, the dose delivered to highly resistant tumours could be increased, significantly fewer treatment sessions would be needed, and there would be additional scope for treating cancers that are currently impossible to treat with radiotherapy,” said Prof. Gilles Créhange, Head of the Radiotherapy Oncology Department at Institut Curie.

FLASH radiotherapy using low-energy electron accelerators has already been shown to be effective for patients undergoing treatment for skin cancers. Work is also in progress on potential applications in intraoperative radiotherapy.

By combining the FLASH effect with a very high-energy electron source, external radiotherapy treatments penetrating deep into human tissue could target deep tumours and avoid major surgical procedures.

A sovereign, world-leading French and European VHEE FLASH ecosystem
Identified as a national priority in the French government's strategy contract for healthcare industries and technologies, the objective is to create a sovereign, world-leading French and European VHEE FLASH ecosystem to treat more cancers and avoid the negative after-effects of radiotherapy.

As the birthplace of radiotherapy more than 100 years ago, Institut Curie has always been at the forefront of innovation in this field and now operates one of Europe's most advanced technical facilities at its Orsay site on the Paris-Saclay University campus.

The new industrial ecosystem will serve as an anchor for other partners and help to safeguard France’s sovereignty in the field of cancer treatment, which is considered a major public health challenge for the next 30 years.

This large-scale project will run for several years and will be conducted in two phases:

• Definition and standardisation of the VHEE FLASH technique by 2026
• Installation of VHEE FLASH equipment in hospitals by 2028

“This partnership with Institut Curie will accelerate research and development into this revolutionary technology. A joint doctoral thesis on the study of radiotherapy using very high-energy electrons (VHEEs) is already underway as the basis for the development of future medical equipment. With its unique experience in complex particle accelerators, Thales has all the industrial resources and know-how needed for this innovative project,” said Charles-Antoine Goffin, Vice President, Microwave and Imaging Subsystems, Thales.

The world’s first facility for human clinical trials
Under the partnership, Institut Curie will work with Thales and other stakeholders to create a new facility to define this new treatment technique, identify priority indications and roll out a comprehensive medical research programme. The facility will be located at Institut Curie’s site in Orsay, in the southwestern suburbs of Paris, which is the only site in France with a suitable clinical setting for this type of equipment. The VHEE FLASH platform will allow the benefits of the technique to be demonstrated in humans, which is a crucial step towards the introduction of the new medical technique in hospitals. The project is the first of its kind in the world and will strengthen Europe’s leadership in this French-developed technology. The ambitious and pioneering collaboration between Institut Curie and Thales is a first step in ensuring that the latest technological and medical innovations are fully exploited in the fight against cancer.

“The expected increase in the number of cancer cases in the decades ahead means we must look for solutions that are more effective and less costly for the healthcare system than those in use or under development today. VHEE FLASH radiotherapy has the potential to meet this demanding requirement.” said Prof. Steven Le Gouill, Director of the Hospital Group at Institut Curie.

“The research by Institut Curie and the speed of its uptake by the scientific community demonstrates the significance of this innovative approach. The challenge will be to raise the necessary funding for industrial scale-up to prevent this French innovation from being developed elsewhere.” said Prof. Alain Puisieux, Director of the Research Centre at Institut Curie.

Institut Curie and Thales (thalesgroup.com) are working with the public authorities to align the funding of this platform with the ambitious goals of the France 2030 investment plan for disruptive medical technologies.

About Institut Curie

Institut Curie (curie.fr), France’s leading cancer centre, combines an internationally renowned research centre with a cutting-edge hospital group, which treats all types of cancer, including the rarest. Founded in 1909 by Marie Curie, Institut Curie employs 3,700 researchers, physicians and health professionals across three sites (Paris, Saint-Cloud and Orsay), all of whom contribute to its three missions of treatment, research and teaching. As a private foundation recognised as a public utility, Institut Curie is authorised to accept donations and bequests, and thanks to the support of its donors, is able to accelerate discoveries and improve patient treatment and quality of life.

Since 2011, Institut Curie (instituts-carnot.eu) is certified as “Institut Carnot Curie Cancer”. The Carnot label is a label of excellence awarded to academic research structures that have demonstrated quality and involvement in collaborative research. Curie Cancer offers industry partners the opportunity to set up research collaborations and benefit from the expertise of Institut Curie teams for the development of innovative treatment solutions for cancer, from biological target to clinical validation. Curie Cancer is a member of the Carnot FINDMED network, a group of 13 Carnot institutes, in order to facilitate access to their technology platforms and innovation capabilities for very small and medium-sized companies, SMEs and SMIs in the pharmaceutical industry.

© Institut Curie / INCa / DUNOUAU Franck

Institut Curie Press Contact: Elsa Champion
P: +33(0)7 64 43 09 28 - E: elsa.champion[.]curie.fr.

Contact: Marion Bonnet, Press and social media manager, Security and Cyber
P: +33(0)6 60 38 48 92 - E: marion.bonnet[.]thalesgroup.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Thales Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Institut Curie and Thales Team to Create World-leading French Industrial Ecosystem in Very High-energy Electron FLASH Radiotherapy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
FLASH Radiotherapy | Thales Group
Contact: Marion Bonnet - ThalesGroup.com 
+33(0)6 60 38 48 92 marion.bonnet[.]thalesgroup.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Thales Group securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Thales Group / Company Profile


Read Medical Services / Equipment Most Recent Related Press Releases:

Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
Top Artificial Intelligence Trends Influencing the Future of Radiology According to Frost & Sullivan
Clarius Applauded by Frost & Sullivan with 2022 North American Portable Ultrasound Technology Innovation Leadership Award
PeriGen Applauded by Frost & Sullivan for Its Innovative Perinatal Software Solutions for Fetal Monitoring and Clinical Decision Support
Bruker Introduces Novel NMR Probe Technology for Biological Research
Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with its Revolutionary Implant RefluxStop™
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
Smart Glove Lauded by Frost & Sullivan for Leading the Global Medical Gloves Industry with Pioneering Products and Creative Innovations
LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with its Interoperable Precision Health So

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Institute of Computer Vision/ Comp. Sciences

Visit  Access Communications Pte Ltd

Heavenly Culture World Peace Restoration







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today